These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30679294)

  • 1. Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis.
    Selvaraj S; Farooqui HH; Mehta A
    BMJ Open; 2019 Jan; 9(1):e024200. PubMed ID: 30679294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008-2018.
    Selvaraj S; Farooqui HH; Mehta A; Mathur MR
    J Pharm Policy Pract; 2022 Oct; 15(1):68. PubMed ID: 36273222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure.
    Lee L; Kim H
    Value Health Reg Issues; 2024 Mar; 40():27-34. PubMed ID: 37972431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications.
    Kwon HY; Godman B
    BMC Health Serv Res; 2016 Apr; 16():130. PubMed ID: 27080530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J; Seeger JD; Donneyong M; Gagne JJ; Avorn J; Kesselheim AS
    JAMA Intern Med; 2016 Sep; 176(9):1317-23. PubMed ID: 27367749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Аn affordability of statins therapy - comparative analysis between Ukraine and Bulgaria.
    Tkachova O; Iakovlieva L; Mitkova Z; Manova M; Savova A; Petrova G
    BMC Health Serv Res; 2019 Nov; 19(1):902. PubMed ID: 31775736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brazilian generics market change after Farmácia Popular program.
    Bertoldi AD; Chaves LA; Ross-Degnan D; Luiza VL; Emmerick ICM; Silva RMD; Campos MR
    Rev Saude Publica; 2019; 53():94. PubMed ID: 31644724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of generic reference pricing interventions in the statin market.
    Puig-Junoy J
    Health Policy; 2007 Nov; 84(1):14-29. PubMed ID: 17368619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.
    Worthington HC; Cheng L; Majumdar SR; Morgan SG; Raymond CB; Soumerai SB; Law MR
    Implement Sci; 2017 Nov; 12(1):141. PubMed ID: 29178960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic atorvastatin, the Belgian statin market and the cost-effectiveness of statin therapy.
    Simoens S; Sinnaeve PR
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):49-60. PubMed ID: 23242669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea.
    Bae G; Park C; Lee H; Han E; Kim DS; Jang S
    BMC Health Serv Res; 2014 Mar; 14():100. PubMed ID: 24589172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.
    Warraich HJ; Salami JA; Khera R; Valero-Elizondo J; Okunrintemi V; Nasir K
    JAMA Intern Med; 2018 May; 178(5):719-721. PubMed ID: 29525818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Price and utilisation differences for statins between four countries.
    Thai LP; Vitry AI; Moss JR
    Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):71-81. PubMed ID: 28800399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic atorvastatin and rosuvastatin in the South Korean market: time of introduction in relation to manufacturer characteristics.
    Son KB
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):541-548. PubMed ID: 31483158
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the Drug Prices Control Order (2013) on the Utilization of Anticancer Medicines in India: An Interrupted Time-Series Analysis.
    Sharma B; Mehta A; Farooqui HH; Negandhi H; Selvaraj S
    Cureus; 2022 Jun; 14(6):e26367. PubMed ID: 35911346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004.
    Hsiao FY; Tsai YW; Huang WF
    BMC Health Serv Res; 2010 Jul; 10():218. PubMed ID: 20653979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Despite increased use and sales of statins in India, per capita prescription rates remain far below high-income countries.
    Choudhry NK; Dugani S; Shrank WH; Polinski JM; Stark CE; Gupta R; Prabhakaran D; Brill G; Jha P
    Health Aff (Millwood); 2014 Feb; 33(2):273-82. PubMed ID: 24493771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013.
    Fuksa L; Vocelka M; Vytrisalova M
    Health Policy; 2015 Sep; 119(9):1255-64. PubMed ID: 25929214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managed care trends in statin usage.
    Bazalo GR
    Manag Care; 2001 Oct; 10(10):48-50, 53-9. PubMed ID: 11688111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.